Imatinib Unknown Status Phase 2 Trials for Gastrointestinal Stromal Tumors Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00290485Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)